Sugi Predict

Sugi Predict / Compounds / SCHEMBL24744722

SCHEMBL24744722

SCHEMBL24744722

Cc1cc(OCCCc2c(C(=O)OC(C)(C)C)n(CCN3CCOCC3)c3c(-c4c(C)nn(CCCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)c4C)cccc23)cc(C)c1Cl

nearest known ligand 0.45

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ GRAMD1A Q96CP6 4/20 0.45
▸ PDE6D O43924 7/20 0.44
▸ DDB1 Q16531 1/20 0.44
▸ CRBN Q96SW2 1/20 0.44
▸ MCL1 Q07820 7/20 0.43
▸ ALB P02768 1/20 0.43
▸ STAT3 P40763 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30000748 1.00 GRAMD1A (0.45) GRAMD1APDE6DDDB1CRBNMCL1
SCHEMBL24744714 0.98 DDB1 (0.45) GRAMD1APDE6DDDB1CRBNMCL1
SCHEMBL30000785 0.98 DDB1 (0.45) GRAMD1APDE6DDDB1CRBNMCL1
SCHEMBL24745172 0.95 PDE6D (0.46) GRAMD1APDE6DDDB1CRBNMCL1
SCHEMBL30000842 0.94 MCL1 (0.50) MCL1ALB
SCHEMBL24744736 0.94 MCL1 (0.50) MCL1ALB
SCHEMBL30000763 0.92 MCL1 (0.51) MCL1ALB
SCHEMBL24745295 0.92 MCL1 (0.51) MCL1ALB
SCHEMBL24745243 0.91 CRBN (0.46) GRAMD1APDE6DDDB1CRBNSTAT3
SCHEMBL24772881 0.90 MCL1 (0.42) MCL1ALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117957218-A Targeted protein degradation using bifunctional compounds that bind to ubiquitin ligases and target MCL-1 proteins 凯普托尔治疗学股份有限公司 2024-04-30 — — CN disclosed
WO-2022255888-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2022-12-08 — — WO disclosed
WO-2022253713-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2022-12-08 — — WO disclosed